Global Oncology Academy

What to Know About PARP Inhibitors for Advanced Ovarian Cancer

ReachMD Healthcare Image
RestartResume

Learn about PARP inhibitors for advanced ovarian cancer, including their mechanism of action, efficacy, safety, and more.

  • Overview

    The treatment landscape for advanced ovarian cancer has changed recently with the addition of PARP inhibitors, which have been shown to prolong patients’ progression-free survival. Discover more about this treatment option, like its mechanism of action, efficacy, and safety, with Dr. Charles Turck and Dr. Joshua Kesterson, Medical Director of the Gynecologic Oncology Program at UPMC in central Pennsylvania.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free